Uremia clinical trials

The registry lists 53 studies for Uremia across more than 10 countries. 10 are recruiting or about to start. 27 of them are mainly about Uremia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Atypical Hemolytic Uremic Syndrome: 123 studies, 29 open.

Get an email when these change. Save the Uremia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Status unknown: 11
Recruiting: 9
Withdrawn: 3
Not yet recruiting: 1

Phase

Phase 4: 10
Phase 2: 8
Phase 1: 3
Phase 3: 2
Early Phase 1: 1

Where

China: 16
Denmark: 6
Italy: 6
Taiwan: 5
United States: 4
France: 2

Who runs them

Bo Feldt-Rasmussen (2) · Region Skane (2) · Hospices Civils de Lyon (2) · Miulli General Hospital (2) · Fuzhou General Hospital (2) · The George Institute (1) · Assaf-Harofeh Medical Center (1) · Dalin Tzu Chi General Hospital (1)

What is being tested here

Drugs under test in Uremia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Anrikefon	1	0	1
Dipyridamole	1	1	1
Gabapentin	0	0	2
Loratadine	0	0	1
Tabalumab	0	0	1
Cysteine	0	0	1
Liraglutide	0	0	1
Ascorbic Acid	0	0	1
Pamidronate	0	0	1
Mycophenolic Acid	0	0	1

Coming up

1phase 3 study under way

4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Dec 2026A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole · Phase 3 · Yunfeng Xia
Dec 2026Timing of Renal Replacement Therapy in the Critically Ill Patients · Karolinska University Hospital
Feb 2027ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms · Azienda Ospedaliera Brotzu
Sep 2027Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets) · VA Office of Research and Development

Who these studies take

Of the 9 Uremia studies recruiting now, 5 (56%) set no upper age limit and 3 (33%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 9
Age	Women	Men
10	0 (0%)	0 (0%)
18	9 (100%)	9 (100%)
30	9 (100%)	9 (100%)
40	9 (100%)	9 (100%)
50	9 (100%)	9 (100%)
65	9 (100%)	9 (100%)
75	9 (100%)	9 (100%)
85	5 (56%)	5 (56%)

Across all 53 studies, recruiting or not: 21% stop at 75 or younger and 9% at 65; 13% take children; 0% are for women only and 2% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Pancreas Transplant Alone in Uremia and Non-uremia PatientsOct 14, 2026NCT07872800

Studies

Recruiting first, then most recently updated. Showing 50 of 53. Browse all 53 → or search them.